Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
Boston Private, BP, China Unicom: 5 Top Stock Gainers for Tuesday
By Rob Lenihan
Jan 5, 2021 4:24 PM EST
PRESS RELEASES
Cerecor Inc. Announces Closing Of $36.4 Million Public Offering Of Common Stock And Pre-Funded Warrants
By GlobeNewswire
Jan 12, 2021 4:01 PM EST
PRESS RELEASES
Cerecor Inc. Announces Pricing Of $36.4 Million Public Offering Of Common Stock And Pre-Funded Warrants
By GlobeNewswire
Jan 7, 2021 10:03 PM EST
PRESS RELEASES
Cerecor Inc. Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants
By GlobeNewswire
Jan 7, 2021 4:01 PM EST
INVESTING
Boston Private, BP, China Unicom: 5 Top Stock Gainers for Tuesday
By Rob Lenihan
Jan 5, 2021 4:24 PM EST
PRESS RELEASES
Cerecor Announces Successful Proof Of Concept Data For CERC-002, A Unique LIGHT-Neutralizing Antibody, In Patients Hospitalized With COVID-19 ARDS
By GlobeNewswire
Jan 5, 2021 7:00 AM EST
PRESS RELEASES
Cerecor Announces FDA Acceptance Of Investigational New Drug Application For CERC-007 For The Treatment Of Still's Disease
By GlobeNewswire
Dec 22, 2020 1:00 PM EST
PRESS RELEASES
Cerecor Announces First Patient Dosed In A Phase 1b Clinical Trial Of CERC-007 For The Treatment Of Relapsed Or Refractory Multiple Myeloma
By GlobeNewswire
Dec 16, 2020 7:00 AM EST
PRESS RELEASES
Cerecor Announces FDA Acceptance Of Investigational New Drug Application For CERC-007 For Treatment Of Relapsed Or Refractory Multiple Myeloma
By GlobeNewswire
Dec 8, 2020 7:00 AM EST
PRESS RELEASES
Cerecor Announces FDA Acceptance Of Investigational New Drug Application For CERC-803 To Treat Leukocyte Adhesion Deficiency Type II
By GlobeNewswire
Dec 1, 2020 7:00 AM EST
PRESS RELEASES
Cerecor Appoints Gilla Kaplan, Ph.D., To The Board Of Directors
By GlobeNewswire
Oct 12, 2020 7:00 AM EDT
PRESS RELEASES
Cerecor To Present At Upcoming Investor Conferences
By GlobeNewswire
Sep 10, 2020 7:00 AM EDT
PRESS RELEASES
Cerecor Announces Peer-Reviewed Publication Highlighting The Role Of The Inflammatory Cytokine, LIGHT, In COVID-19 ARDS
By GlobeNewswire
Aug 13, 2020 7:00 AM EDT
PRESS RELEASES
Cerecor To Present At The 2020 Wedbush PacGrow Healthcare Virtual Conference
By GlobeNewswire
Aug 5, 2020 7:00 AM EDT
PRESS RELEASES
Cerecor Receives Orphan Drug Designation For CERC-006 In Lymphatic Malformations
By GlobeNewswire
Aug 3, 2020 7:00 AM EDT
PRESS RELEASES
Cerecor Announces First Patient Enrolled In Multicenter Proof-of-Concept Study Evaluating CERC-002 For COVID-19 ARDS
By GlobeNewswire
Jul 21, 2020 7:00 AM EDT
PRESS RELEASES
Cerecor Inc. Announces Closing Of $37.95 Million Public Offering And Full Exercise Of Underwriter's Option To Purchase Additional Shares
By GlobeNewswire
Jun 11, 2020 1:30 PM EDT
PRESS RELEASES
Cerecor Inc. Announces Pricing Of $33,000,000 Public Offering Of Common Stock
By GlobeNewswire
Jun 9, 2020 9:05 AM EDT
PRESS RELEASES
Cerecor Inc. Announces Proposed Public Offering Of Common Stock
By GlobeNewswire
Jun 8, 2020 4:01 PM EDT
PRESS RELEASES
Cerecor To Present At The Jefferies Virtual Healthcare Conference
By GlobeNewswire
May 29, 2020 7:00 AM EDT
PRESS RELEASES
Cerecor Announces FDA Clearance Of IND For CERC-002 In COVID-19 Induced ARDS
By GlobeNewswire
May 28, 2020 7:00 AM EDT
PRESS RELEASES
Cerecor And Myriad Genetics Announce That Levels Of LIGHT, A Novel Cytokine, Were Highly Correlated With Disease Severity And Mortality In COVID-19 ARDS Biomarker Study
By GlobeNewswire
May 26, 2020 7:00 AM EDT
PRESS RELEASES
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Cerecor Inc. For Potential Breaches Of Fiduciary Duty By Its Board Of Directors
By PR Newswire
May 4, 2020 9:15 AM EDT
PRESS RELEASES
Cerecor Announces Changes To Board Of Directors
By GlobeNewswire
Apr 24, 2020 1:45 PM EDT
PRESS RELEASES
Cerecor Announces Exploration Of The Role Of An Inflammatory Cytokine, LIGHT, In COVID-19 Patients With Acute Lung Injury Leading To Acute Respiratory Distress Syndrome
By GlobeNewswire
Mar 26, 2020 6:30 AM EDT
